Fluxion
Fluxion Bio Wins $280K NIH Grant to Develop NIPT Assay
The firm will validate a model system for test development, integrate key test components, and compare Spotlight to other NIPT assays.
The firm is partnering with the Cleveland Clinic to validate its mutation variant caller platform in hepatocellular cancer cell-free tumor DNA samples.
Fluxion, Harvard Bioscience Ink Distribution Deal
Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers.
Fluxion Bioscience, UTHealth Collaborate on Liquid Biopsy Development
Both institutions aim to develop novel liquid biopsy approaches that would improve physicians' ability to diagnose, monitor, and treat cancer patients.
Jun 18, 2014
Fluxion, Stanford Team on CTC Test Development
Jun 28, 2012
Fluxion, Stanford Co-Developing Tests for CTCs
Jun 5, 2012
Fluxion, Rubicon Team on CTC Applications
Dec 4, 2009
Fluxion Biosciences Expands into Asian Market
Aug 20, 2009
Fluxion Nets $1.8M NIH Grant
Jul 23, 2009
Fluxion Nets $200K SBIR Grant
Apr 22, 2009
Fluxion Taps EuroClone as Distributor
Feb 27, 2009